Can a common steroid help brain injury recovery? new trial aims to find out
NCT ID NCT07180277
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a 5-day course of the steroid methylprednisolone can improve long-term recovery in adults with moderate to severe traumatic brain injury. 520 participants will receive either the drug or a placebo, added to standard care. Researchers will measure neurological outcomes and safety at 1 and 6 months after injury.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methylprednisolone (a steroid anti-inflammatory drug)
- What this could lead to
- If it works, this could provide a safe, standard treatment to improve recovery and reduce disability after traumatic brain injury.
- What could go wrong
- This is a Phase 4 trial, but prior steroid studies in TBI have shown mixed results or harm. The 5-day course may not improve outcomes and could increase infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?